상세 보기
Safety, efficacy, and pharmacodynamic (PD) activity of 12 weeks treatment with oral RIG-I agonist, inarigivir (IRIG), plus 48 weeks of tenofovir alafenamide in adult patients with chronic hepatitis B: a phase 2 collaboration study
- Lim, Young-Suk;
- Hui, Aric J.;
- Jang, Jeong-Won;
- Tak, Won-Young;
- Ahn, Sang Hoon;
- 외 13명
Citations
WEB OF SCIENCE
0- 제목
- Safety, efficacy, and pharmacodynamic (PD) activity of 12 weeks treatment with oral RIG-I agonist, inarigivir (IRIG), plus 48 weeks of tenofovir alafenamide in adult patients with chronic hepatitis B: a phase 2 collaboration study
- 저자
- Lim, Young-Suk; Hui, Aric J.; Jang, Jeong-Won; Tak, Won-Young; Ahn, Sang Hoon; Jang, Byoung Kuk; Tsang, Tak Yin Owen; Kim, Won; Yang, Jenny; Chen, Diana; McDonald, Circe; Zhang, Liao; Gaggar, Anuj; Gao, Bing; Byun, Kwan Soo; Lee, Kwan Sik; Yim, Hyung Joon; Chan, Henry L. Y.
- 발행일
- 2021-07
- 유형
- Meeting Abstract
- 권
- 75
- 페이지
- S757 ~ S757
- 언어
- ENG
- 출판사
- ELSEVIER
- 발행국가
- 네덜란드
- ISSN
- E 1600-0641
P 0168-8278